Mesa Laboratories (MLAB) Financials

$130.65

$5.18 (4.13%)

As on 02-Sep-2026 16:00EDT

Market cap

$722 Mln

Revenue (TTM)

$250 Mln

P/E Ratio

151.9

P/B Ratio

3.8

Div. Yield

0.5 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Operating Revenue	249.73	249.13	240.98	216.19	219.08	184.34
Cost of Revenue	84.94	90.86	90.11	82.94	85.39	75.25
Gross Profit	164.79	158.27	150.87	133.25	133.69	109.09
Operating Expenses	142.31	139.76	134.53	405.33	130.37	104.39
Operating Profit (EBIT)	22.48	18.51	16.34	-272.08	3.32	4.70
Other Income	--	--	--	--	1.06	--
Profit before Tax	9.36	12.01	5.96	-275.65	-0.39	3.57
Provision for Tax	4.56	5.30	7.94	-21.40	-1.32	1.70
Profit after Tax (Net Income)	4.80	6.71	-1.97	-254.25	0.93	1.87
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	0.93	1.87

Liabilities ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Shareholder's Funds	188.76	186.25	159.83	145.39	393.48	393.80
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	173.14	179.60	109.56	257.09	224.99	265.51
Current Liabilities	49.65	61.90	163.96	44.31	43.36	48.06
Total Liabilities	468.87	427.75	433.35	446.80	661.83	707.37

Assets ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Non-Current Assets	316.38	321.48	330.66	337.44	542.86	583.05
Current Assets	102.85	106.27	102.69	109.35	118.98	124.32
Total Assets	522.07	427.75	433.35	446.80	661.83	707.37
Total Debt*	101.36	168.83	181.47	231.30	186.14	221.13
Net Current Assets	--	44.37	-61.28	65.04	75.62	76.26

Cashflow ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Cash From Operating Activities	--	42.83	46.81	44.13	27.98	39.22
Cash Flow from Investing Activities	--	-3.25	-4.50	-81.31	-9.49	-305.23
Cash from Financing Activities	--	-41.85	-44.51	32.84	-33.33	52.58
Net Cash Inflow / Outflow	--	--	--	--	-14.84	--

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Adjusted EPS ($)	0.85	1.21	-0.36	-47.13	0.17	0.36
Cash EPS ($)	--	5.41	4.15	-41.28	6.46	5.13
Adjusted Book Value ($)	--	33.59	29.44	26.95	73.12	74.97
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	7.73	8.62	8.18	5.20	7.47
Free Cash Flow per Share ($)	--	7.14	7.79	7.71	4.36	6.62

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
ROCE (%)	--	1.93	-0.55	-53.17	0.16	0.32
ROE (%)	2.56	3.88	-1.29	-94.36	0.24	0.47
ROA (%)	0.87	1.56	-0.45	-45.87	0.14	0.29
EBIT Margin (%)	7.05	4.82	7.39	-124.87	2.00	4.05
Net Margin (%)	1.92	2.69	-0.82	-117.60	0.42	1.01
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Revenue Growth (%)	3.04	0.03	0.11	-0.01	0.19	0.38
EBIT Growth (%)	-10.33	-32.58	106.60	-6,261.86	-41.27	-27.77
Net Profit Growth (%)	874.19	440.02	99.22	-27,438.28	-50.29	-42.85
EPS Growth (%)	710.00	4.33	0.99	-273.72	-0.51	-0.42
Book Value Growth (%)	5.55	--	--	--	--	--

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Price / Earnings	151.87	73.03	-326.35	-2.33	1,010.99	715.60
Price / Book Value	3.82	2.63	4.03	4.07	2.39	3.40
Dividend Yield (%)	0.50	--	--	--	--	--
EV/EBITDA	19.38	17.91	18.85	-3.33	29.15	46.44
Close Price ($)	99.55	88.42	118.66	109.73	174.73	254.88
High Price ($)	113.99	129.61	155.12	187.75	263.40	333.42
Low Price ($)	55.45	55.45	83.68	82.86	114.21	232.88
Market Cap ($ Cr)	722.37	--	--	--	--	--

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debt to Equity	--	0.91	1.14	1.59	0.47	0.56
Short term debt to equity ratio	0.04	0.05	0.65	0.02	0.01	0.01
Current Ratio	2.07	1.72	0.63	2.47	2.74	2.59
Quick Ratio	1.52	1.29	0.47	1.73	1.94	2.07
Interest Coverage	1.86	1.12	1.50	-47.38	0.92	1.92

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debtors to sales (%)	13.78	17.70	17.42	18.07	19.42	22.36
Asset Turnover	0.45	0.58	0.55	0.39	0.32	0.28
Receivable days	--	63.09	61.40	68.94	69.83	64.41
Inventory Days	--	103.99	117.63	148.23	126.72	86.85
Payable days	--	21.46	23.89	26.81	30.01	30.02
Cash Conversion Cycle	--	145.63	155.15	190.36	166.54	121.24

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.